Actively Recruiting

Age: 18Years +
All Genders
NCT07357311

Screening and Care for Fear of Cancer Recurrence in Patients With Cancer at Institut Curie

Led by Institut Curie · Updated on 2026-01-23

200

Participants Needed

1

Research Sites

120 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The goals of this study is to establish the prevalence of severe forms of FCR in the oncology hospital setting, which will require a specific psychotherapeutic response. Two cancer sites are targeted: breast and pulmonary cancers. Secondary objectives include: 1) Determining threshold scores for the FCRI's 9-item severity scale for each type of cancer; 3) To identify a simple item from the FCRI for early detection of FCR in everyday clinical practice, especially using a digital format.

CONDITIONS

Official Title

Screening and Care for Fear of Cancer Recurrence in Patients With Cancer at Institut Curie

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Aged 18 or over
  • Clinical or pathological diagnosis of primary or recurrent localized, loco-regional, or metastatic breast cancer
  • Diagnosis of stage 1, 2, 3, or 4 lung cancer or breast or lung cancer metastatic progression
  • At least three months after completing treatment or three months after starting first-line treatment for metastatic progression
  • Able to comply with scheduled assessments and interviews
  • Able to read and understand French questionnaires
Not Eligible

You will not qualify if you...

  • Currently participating in another patient-reported outcome study that interferes with this study
  • Having any social, medical, or psychological condition that prevents completing questionnaires
  • Being deprived of personal liberty or under guardianship

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Institut Curie

Paris, France, 75005

Actively Recruiting

Loading map...

Research Team

A

Anne Bredart, Ph.D

CONTACT

C

Carole Cagnot

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here